CTXR
Price
$1.23
Change
+$0.08 (+6.96%)
Updated
Sep 5 closing price
Capitalization
20.92M
EVGN
Price
$1.20
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
10.82M
67 days until earnings call
Interact to see
Advertisement

CTXR vs EVGN

Header iconCTXR vs EVGN Comparison
Open Charts CTXR vs EVGNBanner chart's image
Citius Pharmaceuticals
Price$1.23
Change+$0.08 (+6.96%)
Volume$270.63K
Capitalization20.92M
Evogene
Price$1.20
Change-$0.00 (-0.00%)
Volume$18.74K
Capitalization10.82M
CTXR vs EVGN Comparison Chart in %
Loading...
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTXR vs. EVGN commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTXR is a Hold and EVGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (CTXR: $1.23 vs. EVGN: $1.20)
Brand notoriety: CTXR and EVGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTXR: 39% vs. EVGN: 22%
Market capitalization -- CTXR: $20.92M vs. EVGN: $10.82M
CTXR [@Biotechnology] is valued at $20.92M. EVGN’s [@Biotechnology] market capitalization is $10.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTXR’s FA Score shows that 1 FA rating(s) are green whileEVGN’s FA Score has 1 green FA rating(s).

  • CTXR’s FA Score: 1 green, 4 red.
  • EVGN’s FA Score: 1 green, 4 red.
According to our system of comparison, both CTXR and EVGN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTXR’s TA Score shows that 3 TA indicator(s) are bullish while EVGN’s TA Score has 2 bullish TA indicator(s).

  • CTXR’s TA Score: 3 bullish, 5 bearish.
  • EVGN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CTXR is a better buy in the short-term than EVGN.

Price Growth

CTXR (@Biotechnology) experienced а -7.52% price change this week, while EVGN (@Biotechnology) price change was -3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

EVGN is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CTXR($20.9M) has a higher market cap than EVGN($10.8M). EVGN YTD gains are higher at: -35.668 vs. CTXR (-69.250). EVGN has higher annual earnings (EBITDA): -14.42M vs. CTXR (-43.9M). EVGN has more cash in the bank: 9.85M vs. CTXR (6.09M). CTXR has less debt than EVGN: CTXR (1.88M) vs EVGN (13M). EVGN has higher revenues than CTXR: EVGN (6.77M) vs CTXR (0).
CTXREVGNCTXR / EVGN
Capitalization20.9M10.8M194%
EBITDA-43.9M-14.42M305%
Gain YTD-69.250-35.668194%
P/E RatioN/A0.30-
Revenue06.77M-
Total Cash6.09M9.85M62%
Total Debt1.88M13M14%
FUNDAMENTALS RATINGS
CTXR vs EVGN: Fundamental Ratings
CTXR
EVGN
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6565
P/E GROWTH RATING
1..100
10088
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTXR's Valuation (8) in the Pharmaceuticals Major industry is in the same range as EVGN (31) in the Biotechnology industry. This means that CTXR’s stock grew similarly to EVGN’s over the last 12 months.

CTXR's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as EVGN (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to EVGN’s over the last 12 months.

CTXR's SMR Rating (98) in the Pharmaceuticals Major industry is in the same range as EVGN (100) in the Biotechnology industry. This means that CTXR’s stock grew similarly to EVGN’s over the last 12 months.

CTXR's Price Growth Rating (65) in the Pharmaceuticals Major industry is in the same range as EVGN (65) in the Biotechnology industry. This means that CTXR’s stock grew similarly to EVGN’s over the last 12 months.

EVGN's P/E Growth Rating (88) in the Biotechnology industry is in the same range as CTXR (100) in the Pharmaceuticals Major industry. This means that EVGN’s stock grew similarly to CTXR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTXREVGN
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 15 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EVGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIXI1.490.08
+5.67%
XIAO-I Corporation
TLSA1.660.08
+5.06%
Tiziana Life Sciences Ltd
BTSG24.130.04
+0.17%
BrightSpring Health Services
SMP39.99-0.01
-0.02%
Standard Motor Products
MSCI555.15-2.04
-0.37%
MSCI

CTXR and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with KLTO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
+6.96%
KLTO - CTXR
36%
Loosely correlated
-2.00%
EVGN - CTXR
35%
Loosely correlated
+0.25%
HYPD - CTXR
34%
Loosely correlated
N/A
ALEC - CTXR
29%
Poorly correlated
+6.74%
VYGR - CTXR
29%
Poorly correlated
+9.28%
More

EVGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVGN has been loosely correlated with CARM. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EVGN jumps, then CARM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVGN
1D Price
Change %
EVGN100%
+0.25%
CARM - EVGN
58%
Loosely correlated
+25.59%
CTXR - EVGN
35%
Loosely correlated
+6.96%
INSM - EVGN
34%
Loosely correlated
+1.80%
PMVP - EVGN
32%
Poorly correlated
+1.39%
ABCL - EVGN
28%
Poorly correlated
+1.44%
More